These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34131820)

  • 21. Immunotherapy for Anaplastic Thyroid Carcinoma.
    Lim AM; Solomon BJ
    J Clin Oncol; 2020 Aug; 38(23):2603-2604. PubMed ID: 32552275
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
    Abe I; Lam AK
    Histol Histopathol; 2021 Mar; 36(3):239-248. PubMed ID: 33170501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon.
    Xu B; Scognamiglio T; Cohen PR; Prasad ML; Hasanovic A; Tuttle RM; Katabi N; Ghossein RA
    Hum Pathol; 2017 Jul; 65():133-139. PubMed ID: 28552827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.
    Al-Jumayli M; Kawsar HI; Neupane P
    Am J Ther; 2022 Nov-Dec 01; 29(6):e714-e716. PubMed ID: 32889810
    [No Abstract]   [Full Text] [Related]  

  • 27. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
    Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N
    Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
    Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiation therapy in thyroid cancer].
    Sun XS; Guevara N; Fakhry N; Sun SR; Marcy PY; Santini J; Bosset JF; Thariat J
    Cancer Radiother; 2013 Jun; 17(3):233-43; quiz 255-6, 258. PubMed ID: 23763764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
    Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
    Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaplastic thyroid cancer.
    Ranganath R; Shah MA; Shah AR
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):387-91. PubMed ID: 26313900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
    Chintakuntlawar AV; Yin J; Foote RL; Kasperbauer JL; Rivera M; Asmus E; Garces NI; Janus JR; Liu M; Ma DJ; Moore EJ; Morris JC; Neben-Wittich M; Price DL; Price KA; Ryder M; Van Abel KM; Hilger C; Samb E; Bible KC
    Thyroid; 2019 Nov; 29(11):1615-1622. PubMed ID: 31595822
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of surgery in the treatment of thyroid anaplastic carcinoma in the elderly.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Rondelli F; Bugiantella W; Barillaro I; Sanguinetti A; Avenia N
    Int J Surg; 2014; 12 Suppl 2():S170-S176. PubMed ID: 25167852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
    Bisof V; Rakusic Z; Despot M
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1553-67. PubMed ID: 24890977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
    Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement.
    Figueiredo AS; Andrea-Ferreira P
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):555-564. PubMed ID: 29886838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
    Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
    Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.